Get the Stockscreener App
293.97
5.83%
16.19
Pre-market:
292.10
-1.87
-0.64%
Overview
News
Price History
Option Chain
Financials
Why HUM Down?
Discussions
Forecast
Dividend History
Humana Inc stock is traded at $293.97, with a volume of 2.23M.
It is up +5.83% in the last 24 hours and up +10.04% over the past month.
Humana is one of the largest private health insurers in the us with a focus on administering Medicare Advantage plans. The firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from individual and group Medicare Advantage, Medicaid, and the military's Tricare program. The firm is also a leader in stand-alone prescription drug plans for seniors enrolled in traditional fee-for-service Medicare. Beyond medical insurance, the company provides other healthcare services, including primary-care services, at-home services, and pharmacy benefit management.
See More
Previous Close:
$277.78
Open:
$283.23
24h Volume:
2.23M
Relative Volume:
0.97
Market Cap:
$34.80B
Revenue:
$115.01B
Net Income/Loss:
$1.36B
P/E Ratio:
12.19
EPS:
24.12
Net Cash Flow:
$-4.34B
1W Performance:
+1.57%
1M Performance:
+10.04%
6M Performance:
-17.24%
1Y Performance:
-41.42%
1-Day Range:
$282.50
$295.72
1-Week Range:
$268.41
$295.72
52-Week Range:
$213.31
$527.18
Humana Inc Stock (HUM) Company Profile
Name
Humana Inc
Sector
Industry
Phone
(502) 580-1000
Address
500 W MAIN ST, LOUISVILLE, KY
Compare HUM with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
| HUM | 293.97 | 34.80B | 115.01B | 1.36B | -4.34B | 24.12 |
| UNH | 600.50 | 543.90B | 389.07B | 14.32B | 13.10B | 23.04 |
| ELV | 397.48 | 91.77B | 174.02B | 6.42B | 871.00M | 25.47 |
| CI | 323.39 | 89.04B | 229.75B | 3.04B | 5.18B | 17.73 |
| CVS | 56.83 | 71.44B | 368.91B | 5.02B | 1.69B | 6.63 |
Humana Inc Stock (HUM) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-26-24 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| Jan-25-24 | Downgrade | Deutsche Bank | Buy → Hold |
| Dec-12-23 | Upgrade | Argus | Hold → Buy |
| Nov-08-23 | Downgrade | BofA Securities | Neutral → Underperform |
| Jul-07-23 | Downgrade | JP Morgan | Overweight → Neutral |
| Jun-23-23 | Downgrade | Argus | Buy → Hold |
| Apr-21-23 | Initiated | Cantor Fitzgerald | Overweight |
| Dec-13-22 | Upgrade | Goldman | Neutral → Buy |
| Oct-26-22 | Upgrade | Deutsche Bank | Hold → Buy |
| Sep-20-22 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Jun-17-22 | Initiated | Loop Capital | Buy |
| May-27-22 | Initiated | Bernstein | Mkt Perform |
| Apr-13-22 | Upgrade | UBS | Neutral → Buy |
| Jan-06-22 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Dec-16-21 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Dec-14-21 | Initiated | Goldman | Neutral |
| Nov-04-21 | Reiterated | Barclays | Overweight |
| Nov-04-21 | Reiterated | Credit Suisse | Outperform |
| Nov-04-21 | Reiterated | Morgan Stanley | Overweight |
| Nov-04-21 | Reiterated | Oppenheimer | Outperform |
| Nov-04-21 | Reiterated | RBC Capital Mkts | Outperform |
| Sep-27-21 | Initiated | SVB Leerink | Outperform |
| Sep-10-21 | Initiated | Cowen | Outperform |
| Sep-09-21 | Resumed | Barclays | Overweight |
| Jul-09-21 | Initiated | Seaport Global Securities | Neutral |
| May-19-21 | Initiated | Wells Fargo | Equal Weight |
| Jan-04-21 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| Oct-02-20 | Initiated | Bernstein | Mkt Perform |
| Jul-01-20 | Initiated | SVB Leerink | Outperform |
| Jun-16-20 | Downgrade | Cowen | Outperform → Market Perform |
| Jun-05-20 | Initiated | Goldman | Buy |
| Jan-03-20 | Reiterated | JP Morgan | Overweight |
| Oct-18-19 | Initiated | Mizuho | Buy |
| Sep-30-19 | Downgrade | BMO Capital Markets | Outperform → Market Perform |
| Sep-12-19 | Initiated | Deutsche Bank | Hold |
| Aug-12-19 | Upgrade | Cantor Fitzgerald | Neutral → Overweight |
| Apr-23-19 | Initiated | UBS | Neutral |
| Jan-14-19 | Initiated | Stephens | Overweight |
| Dec-20-18 | Upgrade | JP Morgan | Neutral → Overweight |
| Nov-08-18 | Reiterated | BofA/Merrill | Buy |
| Sep-13-18 | Initiated | Barclays | Overweight |
| Jul-12-18 | Resumed | Morgan Stanley | Overweight |
| Jul-06-18 | Reiterated | Piper Jaffray | Overweight |
| Jun-01-18 | Resumed | Citigroup | Buy |
| Feb-08-18 | Upgrade | Credit Suisse | Neutral → Outperform |
| Feb-08-18 | Reiterated | Leerink Partners | Outperform |
| Jan-12-18 | Upgrade | Jefferies | Hold → Buy |
View All
Humana Inc Stock (HUM) Latest News
Humana Inc. stock outperforms competitors on strong trading day - MarketWatch
Humana Inc. (NYSE:HUM) Shares Acquired by Ontario Teachers Pension Plan Board - MarketBeat
Here's Why Humana (NYSE:HUM) Can Manage Its Debt Responsibly - Yahoo Finance
Mutual of America Capital Management LLC Increases Stock Holdings in Humana Inc. (NYSE:HUM) - MarketBeat
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Humana Inc.HUM - PR Newswire
Mawer Investment Management Ltd. Lowers Position in Humana Inc. (NYSE:HUM) - MarketBeat
Humana Inc. (NYSE:HUM) Stock Holdings Raised by Empowered Funds LLC - MarketBeat
S&CO Inc. Increases Position in Humana Inc. (NYSE:HUM) - MarketBeat
Kinsale Capital Group Inc. Increases Stake in Humana Inc. (NYSE:HUM) - MarketBeat
KBC Group NV Cuts Stock Position in Humana Inc. (NYSE:HUM) - MarketBeat
Victory Capital Management Inc. Trims Position in Humana Inc. (NYSE:HUM) - MarketBeat
Humana Inc. (NYSE:HUM) Sees Significant Increase in Short Interest - MarketBeat
Mizuho Securities USA LLC Buys 84,897 Shares of Humana Inc. (NYSE:HUM) - MarketBeat
Humana Inc. (NYSE:HUM) Receives $315.86 Average PT from Analysts - MarketBeat
Humana Inc. stock underperforms Friday when compared to competitors - MarketWatch
Humana and Evolent expand partnership to enhance oncology care - The Cancer Letter
FY2024 Earnings Forecast for Humana Issued By Zacks Research - MarketBeat
Investors in Humana (NYSE:HUM) have unfortunately lost 44% over the last year - Yahoo Finance
Humana Inc. stock underperforms Thursday when compared to competitors - MarketWatch
Sivik Global Healthcare LLC Boosts Holdings in Humana Inc. (NYSE:HUM) - MarketBeat
Do You Believe in Humana Inc. (HUM)’s Long-Term Strength? - Insider Monkey
Several Headwinds Dragged Humana (HUM) in Q3 - MSN
Sumitomo Mitsui Trust Group Inc. Increases Stock Position in Humana Inc. (NYSE:HUM) - MarketBeat
Humana Medicare Advantage Plans 2021 - Healthline
Humana adds to C-suite - The Business Journals
Tarsus Welcomes Kate Goodrich, M.D., MHS, to its Board of Directors - The Manila Times
Tarsus Pharma Strengthens Board with Humana CMO Dr. Kate Goodrich Appointment | TARS Stock News - StockTitan
Assetmark Inc. Grows Position in Humana Inc. (NYSE:HUM) - MarketBeat
Humana Stock Slumps as Cigna Says It's Not Pursuing Combination - MSN
Community Health sues Humana to recover $7.3M in payments for drugs to low-income and uninsured - Inside INdiana Business
Humana Inc. stock outperforms competitors despite losses on the day - MarketWatch
Humana Medicare Advantage Review 2024 - Forbes
Humana Appoints Michelle O'Hara as Chief Human Resources Officer - Business Wire
Insurance plans evaluation leads to termination of Humana, Aetna MAs at MyMichigan Health - Iosco County News Herald
Cigna ends merger talks with Humana - Business Insurance
Cigna denies speculation of a Humana deal - Health & Protection
Cigna Ends Humana Merger Speculation: CI Jumps 7.3% While HUM Slips - Yahoo Finance
GSA Capital Partners LLP Has $2.89 Million Stock Holdings in Humana Inc. (NYSE:HUM) - MarketBeat
Entropy Technologies LP Acquires Shares of 14,767 Humana Inc. (NYSE:HUM) - MarketBeat
Cigna drops Humana merger talksLouisville Business First - The Business Journals
Best Insurance Companies for Medicare Advantage in 2025 - U.S. News & World Report
Cigna says they are no longer pursuing merger with Humana - WHAS11.com
Humana Recognized for Commitment to Veteran Employment by Military Times and Military Friendly - Business Wire
Why Cigna Stock Popped Today - The Motley Fool
Why Cigna Deal With Humana Made Little Sense To Begin With - Forbes
Humana (NYSE:HUM) Shares Gap DownHere's What Happened - MarketBeat
Cigna-Humana fallout, Trump 2.0 impact: Catalysts - Yahoo Finance UK
Cigna confirms it won’t pursue combination with rival Humana - Indianapolis Business Journal
Cigna says it is not pursuing deal with rival Humana, shares rise - Reuters
Cigna nixes speculation of a Humana merger - Healthcare Finance News
Cigna Crushes Humana Merger Hopes, Sends Stock Soaring Nearly 8% - Yahoo Finance UK
Humana Inc Stock (HUM) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.23%
5.61%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):